Soaanz FDA Approval History
Last updated by Judith Stewart, BPharm on June 29, 2021.
FDA Approved: Yes (First approved June 14, 2021)
Brand name: Soaanz
Generic name: torsemide
Dosage form: Tablets
Company: Sarfez Pharmaceuticals
Treatment for: Edema
Soaanz (torsemide) is a loop diuretic indicated for the treatment of edema associated with heart failure or renal disease in adults.
- Soaanz is an improved formulation of the approved loop diuretic torsemide intended to reduce excessive urination. Soaanz has an extended duration of peak effect and takes a longer time to achieve peak effect compared to previous torsemide formulations.
- Soaanz tablets are taken orally once daily.
- Soaanz can cause lightheadedness and possibly syncope. This can happen during the first days of therapy, or when there is a drop in blood pressure due to inadequate fluid intake, excessive perspiration, diarrhea, or vomiting.
Development timeline for Soaanz
|Jun 21, 2021
|Approval FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.